SOME RISK FACTORS ASSOCIATED WITH MASKED HYPERTENSION IN DIABETES TYPE 2 PATENTS TREATED IN THAI BINH MEDICAL UNIVERSITY HOSPITAL IN 2020

Vũ Thanh Bình1,, Nguyễn Lệ Thủy1, Trần Thị Nương1, Lê Đức Cường1
1 Thai Binh University of Medicine and Pharmacy

Main Article Content

Abstract

Objective: To Identify risk factors associated with masked hypertension (MH) in diabetes type 2 patents treated in Thai Binh Medical University Hospital in 2020. Subjects and Methods: a cross-sectional study conducted from Jan - October 2020 in 186 diabetes type 2 patients treated in hospital of Thai Binh University of Medicine and Pharmacy. Results: by using APBM, 106 patients were detected having MH among 186 diabetes type 2 patients. Patients with BMI ≥ 23 were more likely having MH higher than patients with BMI > 23 (OR: 6.9; 95% CI: 3.4 – 14.2). MH were more likely to occur in patients who have family history of hypertension (OR = 5.5; 95% CI: 2.3 – 12.5). Patients with high normal clinic BP were more likely to diagnose of MH significantly (OR = 8.7; 95% CI: 4.4 – 17.5). Smoking and drinking patients have higher risk of MH (OR = 2.1; 95% CI: 1.1 – 4.0; OR = 2.0; 95% CI: 1.02 – 4.1, respectively). Patients with history of dyslipidemia have remarkably more risk of MH than normal patients (OR = 3.4; 95% CI: 1.8 – 6.3).  Others possible risks of MH included: duration from diabetes diagnosed > 5 years; increasing uric acid. No significant statistical difference associated with MH found, related to gender, age, proteinuria level. Conclusion: possible risk of MH in diabetes patients included: BMI ≥ 23, having family history of hypertension, high normal clinic BP.

Article Details

References

1. Marchesi C., Maresca A.M., Solbiati F. và cộng sự. (2007). Masked hypertension in type 2 diabetes mellitus. Relationship with left-ventricular structure and function. American Journal Hypertens, 20(10), 1079–1084.
2. Nguyễn Trần Tuyết Trinh (2013), Khảo sát tình hình tăng huyết áp ẩn giấu ở bệnh nhân đái tháo đường týp 2, Luận văn bác sỹ nội trú, Trường Đại học Y Dược Thành Phố Hồ CHí Minh.
3. Wijkman M., Länne T., Engvall J. và cộng sự. (2009). Masked nocturnal hypertension a novel marker of risk in type 2 diabetes. Diabetologia, 52(7), 1258.
4. Nguyễn Văn Huấn (2014), Đặc điểm tăng huyết áp và một số yếu tố liên quan đến kết quả điều trị ở bệnh nhân đái tháo đường týp 2, Luận văn thạc sỹ, Đại học Y Dược Thái Nguyên.
5. Marchesi C, Maresca AM, và Solbiati F (2007). Masked hypertension in type 2 diabetes mellitus. American Journal of Hypertension, 20, 1079–1084.
6. Adler AI. và Stratton IM (2014). Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. British Medical Journal, 321, 412–419.
7. Thakkar H.V., Pope A., Anpalahan M. (2020). Masked Hypertension: A Systematic Review. Heart Lung Circulation, 29(1), 102–111.
8. Kario K., Park S., Chia Y.-C. et al (2020). Consensus summary on the management of hypertension in Asia from the HOPE Asia Network. Journal of Clinical Hypertens (Greenwich), 22(3), 351–362.